SCHEMBL91364

SCHEMBL91364

COCCCc1c[nH]c2ccc(C)cc12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.63
HTR1D P28221 4/20 0.63
MAPT P10636 3/20 0.54
MEN1 O00255 1/20 0.54
LMNA P02545 1/20 0.54
HTT P42858 1/20 0.54
KMT2A Q03164 1/20 0.54
MTNR1A P48039 1/20 0.53
MTNR1B P49286 1/20 0.53
HTR1A P08908 3/20 0.52
HTR1B P28222 3/20 0.52
SLC6A4 P31645 2/20 0.52
HTR2C P28335 2/20 0.52
HTR7 P34969 2/20 0.52
HTR6 P50406 2/20 0.52
ADRA2A P08913 1/20 0.52
DRD2 P14416 1/20 0.52
ADRA2B P18089 1/20 0.52
ADRA2C P18825 1/20 0.52
HTR1E P28566 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13962815 0.84 SLC6A4 (0.66) HTR2AHTR1DMAPTMTNR1AMTNR1B
SCHEMBL13962824 0.84 SLC6A4 (0.66) HTR2AHTR1DMAPTMTNR1AMTNR1B
SCHEMBL1520131 0.81 HTR2A (0.82) HTR2AHTR1DMAPTMEN1LMNA
SCHEMBL27929459 0.81 HTR2A (0.67) HTR2AHTR1DMAPTMEN1LMNA
SCHEMBL78477 0.81 HTR1D (0.66) HTR2AHTR1DMAPTHTR1AHTR1B
SCHEMBL31215137 0.80 HTR1D (0.65) HTR2AHTR1DMAPTMEN1LMNA
SCHEMBL8243669 0.80 SLC6A4 (0.62) HTR2AHTR1DMAPTMEN1LMNA
SCHEMBL8344495 0.79 HTR1D (0.73) HTR2AHTR1DMAPTMEN1LMNA
SCHEMBL18932886 0.78 HTR2A (0.71) HTR2AHTR1DMAPTMEN1LMNA
SCHEMBL2831695 0.78 HTR2A (0.71) HTR2AHTR1DMAPTMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129538-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-06 US disclosed
EP-1717226-B1 2,7-SUBSTITUTED 5-AMINO-4-HYDROXY-8-(1H-INDOL-5-YL)-OCTAN AMIDE DERIVATIVES AS RENIN INHIBITORS FOR THE TREATMENT OF HYPERTENSION SPEEDEL EXPERIMENTA AG (CH) 2009-01-21 EP disclosed